Boehringer Ingelheim Pharmaceuticals, Inc., Makes $500,000 Donation to Support COVID-19 Related Activities by American Thoracic Society
April 08, 2020
April 08, 2020
NEW YORK, April 8 -- The American Thoracic Society issued the following news release:
The American Thoracic Society announced that Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. . . .
The American Thoracic Society announced that Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. . . .